MEDIROM Healthcare Technologies Inc. Unsponsored ADR

MRM Consumer Cyclical Personal Services

MEDIROM Healthcare Technologies Inc. Unsponsored ADR’s revenue for fiscal 2024 (year ended December 2024) was $54.8 million, up 13.0% from fiscal 2023.

0.36 0.02 −5.26%
Market cap
$3.0M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
6/9
Altman Z
0.91
Beneish M
−1.22
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 27.62%

Capital & Financial Ratios $m

Market Cap 2.99
Revenue 80.45
Net Income (84.29)
Free Cash Flow (128.34)
Net Debt 13.33
Current Ratio 0.24 (below 1: weak)
Debt/Equity 6.61 (above 2: weak)
P/E ratio —
Fwd P/E —
P/S ratio 0.02
P/B ratio 0.70
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next Y revenue growth 8.22%
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/S against its own 10 years 0.30%
10-year low 10-year high
P/B against its own 10 years 11.71%
10-year low 10-year high
EV/Sales against its own 10 years 7.29%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2020 Powerpack
2019 Powerpack
2018 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2022 2023 2024 Q'25
Cash 5 1 2 0
Receivables 10 9 13 5
Inventory 1 1 1 1
Other — — — —
18 12 18 8
2022 2023 2024 Q'25
Payables 2 1 7 10
ST’ Debt 1 4 7 9
Other 9 6 6 7
28 25 28 34

Compound Annual Growth %

10y 5y 3y
Sales — 8.85% 3.62%
Cash Flow — 0.00% 0.00%
Earnings — 43.92% 0.00%
Book Value — 3.38% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’24 — — — — 55
’23 — — — — 48
’22 — — — — 54
’21 — — — — 49
’20 — 13 — — 31
’19 — 18 — — 36
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’24 — — — — (9)
’23 — — — — (4)
’22 — — — — (5)
’21 — — — — (5)
’20 — (3) — — (3)
’19 — 2 — — 0
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — (3) — — —
’24 — (111) — (9) (13)
’23 — (5) — (5) (11)
’22 — (3) — (6) (6)
’21 — (4) — (6) (6)
’20 — (3) — (4) (4)
’19 — 2 — — 0
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’24 — — — — 0.19
’23 — — — — 0.16
’22 — — — — 0.21
’21 — — — — (1.85)
’20 — (1.02) — — (1.26)
’19 — 0.12 — — 0.04
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Trend 2025e 2026e 2027e
Price, $
Price, $ Low — — — — — 13.62 5.46 4.32 3.50 0.90

Analyst estimates 2025–2027

Powerpack
High — — — — — 19.80 19.45 9.80 7.40 8.39
People
People Employees — — — — 417 571 913 979 1,101 1,051
Revenue/emp, $m — — — 0.00 0.09 0.06 0.05 0.05 0.04 0.05
Income, $m
Income, $m Revenue — — — 31 36 31 49 54 48 55
Gross margin, % — — — 27.87 24.33 12.84 26.16 27.36 22.98 27.07
EBT — — — 1 0 (6) (4) 1 0 0
EBT margin, % — — — 2.68 0.84 (18.75) (7.66) 2.59 0.30 0.57
Net income — — 0 1 0 (5) (9) 1 1 1
Depreciation — — — 0 0 1 1 1 2 2
Per share, $
Per share, $ Revenue — — — 7.73 8.91 7.80 10.09 10.98 9.93 10.72
Earnings — — — — — (1.26) (1.85) 0.23 0.17 0.19
Cash flow — — — 0.32 0.02 (0.86) (1.04) (1.08) (0.92) (1.72)
Capex — — — 0.00 0.00 (0.16) (0.18) (0.13) (1.34) (0.73)
Free cash flow — — — 0.32 0.02 (1.02) (1.22) (1.21) (2.26) (2.45)
Book value — — — (0.27) 1.37 1.15 (0.39) (0.09) 0.31 1.28
Shares, m — — — 4 4 4 5 5 5 5
Valuation, ×
Valuation, × P/E — — — — — — — — — —
P/S — — — 0.00 0.00 0.00 0.30 0.23 0.29 0.05
P/B — — — 41.74 41.74 12.54 0.00 0.00 15.05 0.64
EV/Sales — — — 0.00 0.00 0.00 0.49 0.41 0.53 0.18
EV/FCF — — — 0.00 0.00 0.00 (2.59) (1.83) (2.28) (0.11)
Cash, $m
Cash, $m Operating cash flow — — — 1 0 (3) (5) (5) (4) (9)
Capex — — — 0 0 (1) (1) (1) (7) (4)
Free cash flow — — — 1 0 (4) (6) (6) (11) (13)
Balance, $m
Balance, $m Working capital — — — (13) (8) (5) (17) (10) (13) (10)
Total debt — — — 26 22 18 19 19 20 12
Net debt — — — 24 17 4 15 14 20 10
Shareholders’ equity — — — (1) 6 5 (2) 0 2 7
Returns, %
Returns, % ROA — — — 2.91 0.77 (10.68) (17.00) 2.20 1.63 1.92
ROIC — — — 0.00 0.00 (50.54) (20.54) 3.42 (8.24) (0.45)
ROE — — — 26.98 7.15 (99.97) (662.46) (97.49) 152.29 24.38
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2024 · latest quarter Jun 2020

Charts ten years each

MEDIROM Healthcare Technologies Inc. Unsponsored ADR vs peers in Personal Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CSV Carriage Services, Inc. $573.8M 12.7× 10.9× +0.79% (above 0%: growing) +4.00% (above 0%: growing) −57.53% (below 0%: shrinking) 34.04% 23.27% Compare
MED MEDIFAST INC $134.8M — (loss-making) — (loss-making) −27.64% (below 0%: shrinking) n/m +115.31% (above 0%: growing) 69.90% (5.66%) Compare
RGS Regis Corporation $73.0M 10.5× — (loss-making) −7.28% (below 0%: shrinking) −96.38% (below 0%: shrinking) −42.31% (below 0%: shrinking) 100.00% 11.81% Compare
CLIK Click Holdings Limited $9.9M — — — — — — — Compare
YFOR YYForce Inc. $6.4M — — — — −1,491.67% (below 0%: shrinking) — — Compare
EJH E-Home Household Service Holdings Limited $4.2M — (loss-making) — — — +1.99% (above 0%: growing) 25.20% 0.00% Compare
IVPR Inspire Veterinary Partners, Inc. $3.2M — (loss-making) — +6.60% (above 0%: growing) n/m +79.07% (above 0%: growing) 18.23% (45.58%) Compare
TRNR Interactive Strength Inc. $3.2M 0.0× — (loss-making) +445.28% (above 0%: growing) n/m +92.02% (above 0%: growing) 48.37% (50.73%) Compare
MRM MEDIROM Healthcare Technologies Inc. Unsponsored ADR $3.0M — — +58.87% (above 0%: growing) n/m +41.57% (above 0%: growing) 32.20% 0.00%
Median of peers $8.1M 10.5× — +0.79% — +1.99% 41.21% (2.83%)

All 15 Personal Services stocks →

MEDIROM Healthcare Technologies Inc. Unsponsored ADR (MRM) key facts

  • Strength: MEDIROM Healthcare Technologies Inc. Unsponsored ADR’s revenue for fiscal 2024 (year ended December 2024) was $54.8 million, up 13.0% from fiscal 2023.
  • Strength: Net income was $912,100.00, or $0.19 per share (basic), a net margin of 1.79%.
  • MEDIROM Healthcare Technologies Inc. Unsponsored ADR (MRM) is a Personal Services company in the Consumer Cyclical sector, traded in the US as an ADR.
  • As of October 16, 2026, MRM traded at $0.36, a market capitalization of $3.0 million.
  • Return on equity was 24.4% and debt-to-equity 6.61.
  • Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 0.91 (distress zone) for fiscal 2024.

Source: company filings (standardised) and stockrow calculations.

MEDIROM Healthcare Technologies Inc. Unsponsored ADR (MRM) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/MRM · Data as of Jun 30, 2020 · For information only; not investment advice. · © 2026 stockrow.com